Pharmaceutical company, Novartis, has the first FDA approved patch for the treatment of Alzheimer’s disease. The advantage of a patch is that medication is released on a more consistent basis than when the medication is given orally. Because the medication is absorbed through the skin, and enters the blood stream directly, the patient’s tolerability is improved.
And now for the rest of the story.
There are important warnings from the manufacturer, Novartis. There appears to be concern when the Alzheimer’s skin patch is used with anti-depressants.